Kelonia Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- April 29, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Company Description
- Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform.
- Market
- Oncology
- Location
- Cambridge, MA, USA
- Coinvestors
- Alta Partners, Horizons Ventures, Venrock